CHEMFAB2025-07-012025-09-30CHEMFAB2025-09-30CHEMFAB2025-03-31CHEMFAB2025-04-012025-09-30CHEMFAB2025-07-012025-09-30in-capmkt:OtherExpenses1MemberCHEMFAB2025-07-012025-09-30in-capmkt:OtherExpenses2MemberCHEMFAB2025-04-012025-09-30in-capmkt:OtherExpenses1MemberCHEMFAB2025-04-012025-09-30in-capmkt:OtherExpenses2MemberCHEMFAB2025-07-012025-09-30in-capmkt:ReportableSegments1MemberCHEMFAB2025-07-012025-09-30in-capmkt:ReportableSegments2MemberCHEMFAB2025-04-012025-09-30in-capmkt:ReportableSegments1MemberCHEMFAB2025-04-012025-09-30in-capmkt:ReportableSegments2MemberCHEMFAB2025-07-012025-09-30in-capmkt:ReportableSegments1MemberCHEMFAB2025-07-012025-09-30in-capmkt:ReportableSegments2MemberCHEMFAB2025-04-012025-09-30in-capmkt:ReportableSegments1MemberCHEMFAB2025-04-012025-09-30in-capmkt:ReportableSegments2MemberCHEMFAB2025-07-012025-09-30in-capmkt:ReportableSegments1MemberCHEMFAB2025-09-30in-capmkt:ReportableSegments1MemberCHEMFAB2025-07-012025-09-30in-capmkt:ReportableSegments2MemberCHEMFAB2025-09-30in-capmkt:ReportableSegments2MemberCHEMFAB2025-07-012025-09-30in-capmkt:ReportableSegments1MemberCHEMFAB2025-09-30in-capmkt:ReportableSegments1MemberCHEMFAB2025-07-012025-09-30in-capmkt:ReportableSegments2MemberCHEMFAB2025-09-30in-capmkt:ReportableSegments2MemberCHEMFAB2025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1CHEMFAB2025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss2CHEMFAB2025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1CHEMFAB2025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss2CHEMFAB2025-07-012025-09-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares541269CHEMFABNOTLISTEDINE783X01023CHEMFAB ALKALIS LIMITEDMain BoardEquity2025-04-012026-03-312025-10-312025-10-25INRLakhsQuarterlySecond quarterMulti segment2025-10-3114:30:002025-10-3117:15:00trueCash Flow IndirectDeclaration of unmodified opinion2025-07-012025-09-30UnauditedConsolidated76561600017579000783195000236499000027843000697050001941100066127000376925000796510000-133150000-133150004441000235100067920000-201070000000-201070001031000-19076000-2010700001031000-1907600014367700010-1.4-1.400-1.4-1.4000NOTES: <BR> <BR> 1 The Statement of Consolidated unaudited financial results comprises of the financial results of Chemfab Alkalis Limited (CAL) (“the Parent Company”) and Chemfab Alkalis Karaikal Limited (CAKL) ("the Subsidiary") (together referred to as “the Group”). These financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Parent Company at their meeting held on 31 October 2025. <BR> <BR> 2 The Group has identified its reportable segments in accordance with Ind AS 108 - Operating Segments. Accordingly, two reportable segments i.e. Chemicals and Related Products and PVC - O Pipes have been identified, the details of which are given below: <BR> (Amount Rs. In Lakhs) <BR> Sl. No. Particulars 3 Months ended 30/09/2025 " Preceding <BR> 3 Months ended 30/06/2025 " " Corresponding <BR> 3 months ended 30/09/2024 in the previous year " Year to date figures for current period ended 30/09/2025 Year to date figures for previous period ended 30/09/2024 Previous year ended 31/03/2025 <BR> (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) <BR> I Segment Revenue <BR> a) Chemicals and related Products 4,981.56 5,283.89 4,737.12 10,265.45 9,297.16 20,292.38 <BR> b) PVC-O Pipes 2,700.36 3,870.20 3,452.50 6,570.56 6,545.57 13,145.05 <BR> 7,681.92 9,154.09 8,189.62 16,836.01 15,842.73 33,437.43 <BR> Less: Inter Segment Revenue (25.76) - - (25.76) - - <BR> Net Segment Revenue 7,656.16 9,154.09 8,189.62 16,810.25 15,842.73 33,437.43 <BR> II Segment Result before tax <BR> a) Chemicals and related Products (862.01) (372.49) (919.41) (1,234.50) (1,556.71) (2,310.07) <BR> b) PVC-O Pipes 747.18 863.16 1,053.86 1,610.34 1,793.38 3,049.01 <BR> Total (114.83) 490.67 134.45 375.84 236.67 738.94 <BR> Less: Inter Segment Result - - - - - - <BR> Less: Finance Cost -194.11 (156.86) (121.83) (350.97) (216.03) (492.50) <BR> Add: Other Income 175.79 136.17 60.12 311.96 319.46 711.79 <BR> Total Profit Before Tax (133.15) 469.98 72.74 336.83 340.10 958.23 <BR> III Segment Assets: <BR> a) Chemicals and related Products 33,367.89 33,569.53 32,502.49 33,367.89 32,502.49 31,617.08 <BR> b) PVC-O Pipes 20,556.75 18,479.55 17,979.06 20,556.75 17,979.06 15,858.21 <BR> Total Segment Assets 53,924.64 52,049.08 50,481.55 53,924.64 50,481.55 47,475.29 <BR> Add: Unallocable assets 2,816.23 2,659.56 2,963.38 2,816.23 2,963.38 4,706.96 <BR> Total Assets 56,740.87 54,708.64 53,444.93 56,740.87 53,444.93 52,182.25 <BR> IV Segment Liabilities: <BR> a) Chemicals and related Products 6,433.91 4,726.49 4,185.63 6,433.91 4,185.63 3,546.82 <BR> b) PVC-O Pipes 1,354.35 1,820.63 2,289.51 1,354.35 2,289.51 2,181.34 <BR> Total Segment Liabilities 7,788.26 6,547.12 6,475.14 7,788.26 6,475.14 5,728.16 <BR> Add: Unallocable liabilities 11,046.62 9,893.48 8,330.22 11,046.62 8,330.22 8,455.28 <BR> Total Liabilities 18,834.88 16,440.60 14,805.36 18,834.88 14,805.36 14,183.44 <BR> <BR> <BR> 3 During the half year ended 30 September 2025, the Parent Company had allotted 4,000 Equity shares of Rs. 10 each upon exercise of Employee stock options by the eligible employees under Employee's Stock Option Scheme "CAESOS 2020". <BR> <BR> 4 The Board of Director's of the Parent Company in their meeting held on 14 May 2025 have approved the sale of Salt Division 2 and consequently assets relating to the said division aggregating to Rs. 2165.04 Lakhs have been classified as Asset held for sale. The sale is expected to be consummated before the end of the financial year. <BR> 5 The Statement of Consolidated Assets and Liabilities as at 30 September 2025 and the Statement of Consolidated Cash Flows are provided as annexures to this Statement. <BR> <BR> For Chemfab Alkalis Limited <BR> <BR> <BR> <BR> Suresh Krishnamurthi Rao <BR> Place: Chennai Chairman <BR> Date: 31 October 2025 DIN No: 00127809 <BR> <BR> 2025-04-012025-09-30UnauditedConsolidated168102500031196000171222100053650800003721500013408400035097000130031000805603000167853800033683000033683000176690001064500028314000053690000000536900022050007574000536900002205000757400014367700010-0.37-0.3700-0.37-0.37000Direct Manufcaturing Expenses - Power Fuel and Others268472000Other Expenses108453000Direct Manufcaturing Expenses - Power Fuel and Others561380000Other Expenses244223000299624100063142000000141160000000110000000227530002385300021835700035450300043655340002601410001020002946920001700008711000030530003067280000286735000853604000454949000056740870001436770003646922000379059900003790599000554250000186140005728640003027200046250006077610005234860004761000353974000358735000616840009439050003019280001660800013286000012757270000018834880005674087000Chemicals and Related products498156000PVC-O Pipes270036000Chemicals and Related products1026545000PVC-O Pipes6570560007681920001683601000257600025760007656160001681025000Chemicals and Related products-86201000PVC-O Pipes74718000Chemicals and Related products-123450000PVC-O Pipes161034000-11483000375840001941100035097000-17579000-31196000-1331500033683000Chemicals and Related products3336789000PVC-O Pipes205567500053924640002816230005674087000Chemicals and Related products643391000PVC-O Pipes135435000778826000110466200018834880003509700011697000-96279000000-2024200000463620000001300310000000099600000154000121000-19770000-810900009354000011586100014954400000037205000011233900000000000245264000764916000000000000000000000193300005937000-511782000003910000000033608600083700000230000011282000342640000-84000204847000-1945960000-194596000194867000271000Remeasurement of net defined benefit liability1453000Fair value gain on investments in equity instruments designated as at FVTOCI10001454000Remeasurement of net defined benefit liability2905000Fair value gain on investments in equity instruments designated as at FVTOCI14600030510004230008460000010310002205000UnauditedfalseDeloitte Haskins and Sells LLPtrue2027-07-31